Mohamed N. Rahaman

Materials for Biomedical Engineering


Скачать книгу

700 000 Hernia mesh Silicone; polypropylene; teflon 200 000 ($4 billion) Sutures Polylactic acid; polydioxanone; polypropylene; stainless steel ($2 billion) Blood bags Polyvinyl chloride — Ear tubes (Tympanostomy) Silicone; teflon 1.5 million Intrauterine device Silicone; copper 1 million

      a Data compiled from many sources – these numbers should be considered rough estimates that are growing with changing markets and new technologies. Where only US numbers are available, world usage is estimated at 2.5 times the US usage.

      Outside of academic institutions, biomaterials are also an important area of research, development, and manufacturing in several industries, such as in the production of medical devices, dental restorations, and devices for drug delivery. The size of companies that manufacture biomaterials and devices for these applications cover a wide range, from small start‐up companies to large established companies that are among the so‐called Fortune 500 companies in the United States. The commercial market for devices that incorporate biomaterials is immense and it is projected to grow at a healthy rate. Estimates of the commercial market and the number of implantable medical devices that incorporate biomaterials annually are presented in Table 1.1.

      Several terms are commonly used in the biomaterials literature and throughout this book. This section provides a description of the meaning and definition of some of these common terms that are particularly relevant to this chapter.

      Biomaterial

       A biomaterial is a nonviable material used in a medical device, intended to interact with biological systems.

      As biomaterials evolved, another definition was proposed:

       A biomaterial is a material intended to interface with biological systems to evaluate, treat, augment, or replace any tissue, organ or function in the body (Williams 1999).

      While these early definitions reflected our understanding and use of biomaterials at that time, they are now too restrictive because of the evolution of biomaterials over the last two to three decades. Biological sciences, as noted earlier, are now playing an increasing role in designing biomaterials. At the same time, advances in engineering have made it possible to create biomaterials with increasing sophistication. Biomaterials are now being studied, developed or created to target specific responses by cells and tissues in the body, regenerate functional tissues and organs, deliver molecules or drugs to target specific cells or tissues, and improve diagnostic imaging of cells and tissues. A recently proposed definition that attempts to capture these more recent advances and broader meaning of the term is:

       A biomaterial is a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure (Williams 2014).

      Biocompatibility

      A widely accepted definition of biocompatibility is:

       Biocompatibility refers to the ability of a material to perform with an appropriate host response in a specific application (Williams 1999).

      Biocompatibility is the most critical factor that determines the success of implanted biomaterials (Chapter 16), but the term is often used loosely in the literature. Biocompatibility is not simply a property of the material alone. As biocompatibility refers to the ability of the biomaterial to perform in a specific application, it is a property of the material–tissue system. It should also be recognized that the biocompatibility phenomena of a given material can change, depending on the situation and the implantation time.

      Host Response

      The host response to a biomaterial refers to the response of cells and tissues of the body, either local or systemic, to the implanted biomaterial.

      Categories of Biomaterials

      Biomaterials can be categorized in a number of different ways, depending on their source or the property being emphasized. As they are widely used in the literature, we provide a description of the meaning and definition of the more common terms related to these categories.

       Natural and Synthetic Biomaterials

      Biomaterials can be classified as natural materials or synthetic materials, depending on their source. Natural biomaterials are materials obtained from human and other vertebrate sources, invertebrate organisms, and from plants. They include bone taken from live humans or cadavers, collagen isolated from animal skin and bones, cellulose produced by certain types of bacteria or obtained from plants, silk from spiders, chitin extracted from the shells of crustaceans, alginate produced by seaweed, and hyaluronic acid extracted from rooster combs or from genetically engineered bacteria. Natural biomaterials are typically similar or identical to substances in living organisms.

       Metals, including their alloys, such as gold; stainless steels; titanium (Ti) and its alloys;

       Ceramics, including glasses and glass‐ceramics, such as aluminum oxide (Al2O3 ); the calcium phosphates hydroxyapatite and β‐tricalcium phosphate; bioactive glasses;

       Polymers